Primary cilium-mediated mechanisms of cyst formation in polycystic kidney disease.
文献摘要
Autosomal-dominant polycystic kidney disease (ADPKD) is characterized by progressive renal cyst formation leading to kidney failure. Mutations in PKD1 or PKD2, encoding polycystins 1 and 2, underlie most cases of ADPKD. Tolvaptan remains the only approved therapy but has limited efficacy and tolerability, underscoring the need for a deeper mechanistic understanding of disease pathogenesis. Polycystins function as cation channels in the primary cilium - a sensory organelle implicated in renal epithelial development and homeostasis. Pioneering genetic studies have established that cilia loss derepresses a cilia-dependent cyst activation programme, revealing the cilium as an active signalling compartment that restrains cystogenesis triggered by polycystin dysfunction. Structural and ciliary trafficking studies have illuminated how cilia-dependent signals drive cystogenesis in development and adult contexts, whereas ciliary length regulation offers a tractable entry point for identifying ciliary effectors. Extraciliary transcriptional and post-transcriptional pathways cooperate with ciliary signalling to modulate disease progression, often through components that serve distinct compartmental functions. Notably, both ciliary and transcriptional effectors converge on mitochondrial metabolism as a critical checkpoint, revealing an integrated cilium-metabolism axis whose disruption facilitates cystogenesis. Together, this integrated structural, functional and regulatory framework for cilia-regulated ADPKD pathogenesis points towards ciliary trafficking machinery and metabolic checkpoints as actionable therapeutic targets.